Form 4: Marimed COO Timothy Shaw Reports Stock Transactions

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports the vesting of restricted stock units and subsequent tax withholding, impacting his beneficial ownership of common stock.

Summary

• On October 27, 2024, Timothy Shaw, the Chief Operating Officer of Marimed Inc., reported transactions involving the company's common stock.
• 111,111 Restricted Stock Units (RSUs) vested and converted into common stock on a one-for-one basis.
• The company withheld 32,612 shares of common stock to satisfy tax withholding obligations related to the RSU vesting at a price of $0.165 per share.
• Following these transactions, Shaw directly owns 8,733,628 shares of common stock.
• Shaw also has indirect ownership of 2,000,000 shares through the Shaw Family Trust, for which he disclaims beneficial ownership.
• The RSUs were granted on October 27, 2022, and vest in installments, with the final vesting dates on April 27, 2025, and October 27, 2025.

Sentiment

Score: 5

Explanation: This is a routine filing related to executive compensation. It doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in company stock. This filing indicates routine vesting of previously granted equity compensation.

Stakeholder Impact

• Shareholders may see this as a routine part of executive compensation.
• Employees may view this as part of the company's compensation structure.

Key Dates